Creative Biolabs is looking for potential partners (include but not limit to major pharma or biotech firms) to develop anti-CCL2/CCR2 axis targeted therapeutic antibody program together. Our scientists are dedicated to bringing together years of valuable experience to our partner and achieve a meaningful partnership. For commercial partners interested in our Next-IO™ programs, Creative Biolabs welcomes collaboration. Learn more: Next-IO™ Anti-CCL2/CCR2 Axis Targeted Therapeutic Antibody Program